The weight-loss benefits of pricey GLP-1 diabetes drugs were a big medical story in 2024, with CMS proposing mandatory Medicare and Medicaid coverage of the drugs for an obesity indication.
Should CMS cover GLP-1 drugs for obesity?
Medpage Today® surveys are polls of those who choose to participate and are, therefore, not valid statistical samples, but rather a snapshot of what your colleagues are thinking